New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Align Technology, Inc.
ALGN
Shape
US Flag

NASDAQ

18B

Medical - Devices

Next Earning date - 23 Oct 2024

18B

Medical - Devices

Next Earning date - 23 Oct 2024

235.30USD
Shape-2.76 ( -1.16%)
Market Open
favorite-chart

Relative Strenght

22
favorite-chart

Volume Buzz

-60%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

30%

Quote Panel

Shape
Updated October 3, 2024
1W -7.46 % 1M 6.05 % 3M -3.20 % 1Y -19.17 %

Key Metrics

Shape
  • Market Cap

    17.58B


  • Shares Outstanding

    74.70M


  • Share in Float

    69.53M


  • Dividende

    0


  • Earning Date

    23 Oct 2024


  • Price Target

    235.3


  • Average Volume

    770049


  • Beta

    1.643


  • Range

    176.34-335.4


  • Industry

    Medical - Devices


  • Website

    https://www.aligntech.com


  • Sector

    Healthcare


Fundamentals

Shape

25.88x

P/E Ratio

4.51x

P/S Ratio

4.76x

P/B Ratio

0.0

Debt/Equity

11.3%

Net Margin

$5.9

EPS

How ALGN compares to sector?

P/E Ratio

Relative Strength

Shape

ALGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4B

Shape328%

2025-Revenue

$8.17

Shape538%

2025-EPS

$875M

Shape308%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

OTR Global

downgrade

Previous: Positive

2024-06-04

Now: Mixed

Redburn Partners

downgrade

Previous: Not converted

2023-09-14

Now: Neutral

Jefferies

upgrade

Previous: Buy

2023-09-14

Now: Hold

Susquehanna

upgrade

Previous: Not converted

2023-09-14

Now: Positive

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-53%

1.36
vs 2.87

Q4.22

arrow
arrow

-39%

1.73
vs 2.83

Q1.23

arrow
arrow

-15%

1.82
vs 2.13

Q2.23

arrow
arrow

+11%

2.22
vs 2

Q3.23

arrow
arrow

+57%

2.14
vs 1.36

Q4.23

arrow
arrow

+40%

2.42
vs 1.73

Q1.24

arrow
arrow

+18%

2.14
vs 1.82

Q2.24

arrow
arrow

+9%

2.41
vs 2.22

Q3.24

arrow
arrow

+8%

2.31
vs 2.14

Q4.24

arrow
arrow

+6%

2.57
vs 2.42

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-12%

890.3M  vs 1B

Q4.22

arrow
arrow

-13%

901.5M  vs 1B

Q1.23

arrow
arrow

-3%

943.1M  vs 973.2M

Q2.23

arrow
arrow

+3%

1B  vs 969.6M

Q3.23

arrow
arrow

+8%

960.2M  vs 890.3M

Q4.23

arrow
arrow

+6%

956.7M  vs 901.5M

Q1.24

arrow
arrow

+6%

997.4M  vs 943.1M

Q2.24

arrow
arrow

+3%

1B  vs 1B

Q3.24

arrow
arrow

+3%

989.9M  vs 960.2M

Q4.24

arrow
arrow

+7%

1B  vs 956.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+2%

0.02
vs 0.03

Q4.22

arrow
arrow

+1%

0.01
vs 0.02

Q1.23

arrow
arrow

+3%

0.03
vs 0.01

Q2.23

arrow
arrow

+3%

0.03
vs 0.03

Q3.23

arrow
arrow

+3%

0.03
vs 0.03

Q4.23

arrow
arrow

+3%

0.03
vs 0.03

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

755

755
vs 767

-2%

Q4.22

arrow
arrow

744

744
vs 755

-1%

Q1.23

arrow
arrow

801

801
vs 744

8%

Q2.23

arrow
arrow

801

801
vs 801

NA

Q3.23

arrow
arrow

845

845
vs 801

5%

Q4.23

arrow
arrow

818

818
vs 845

-3%

Q1.24

arrow
arrow

842

842
vs 818

3%

Q2.24

arrow
arrow

778

778
vs 842

-8%

Earnings Growth

Latest News